…
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | -20.70M | -166.27M | -9.09M | -16.72M | -16.72M |
| Minority interest | 0.04M | 0.49M | 0.06M | -0.11M | -0.00M |
| Net income | -18.67M | -134.98M | -9.46M | -16.85M | -16.85M |
| Selling general administrative | 3.99M | 3.64M | 8.59M | 15.39M | 15.39M |
| Selling and marketing expenses | - | - | 0.17M | 0.24M | 0.24M |
| Gross profit | -0.01M | -0.28M | 0.12M | 0.92M | 0.92M |
| Reconciled depreciation | 2.37M | 2.15M | 0.00M | - | 0.02M |
| Ebit | -4.00M | -3.92M | -9.22M | -15.13M | -15.13M |
| Ebitda | -1.63M | -1.77M | -8.64M | -15.90M | -15.90M |
| Depreciation and amortization | 2.37M | 2.15M | 0.14M | -0.76M | -0.76M |
| Operating income | -4.00M | -166.30M | -8.64M | -15.13M | -15.13M |
| Other operating expenses | 17.83M | 181.08M | 11.05M | 21.44M | 21.44M |
| Interest expense | - | - | 0.00M | 0.80M | 0.80M |
| Tax provision | -1.99M | -30.80M | 0.02M | 0.02M | 0.13M |
| Net interest income | - | - | 0.00M | 0.00M | -0.80M |
| Income tax expense | -1.99M | -30.80M | 0.02M | 0.13M | 0.13M |
| Total revenue | 13.83M | 14.78M | 2.41M | 6.31M | 6.31M |
| Total operating expenses | 3.99M | 166.02M | 8.76M | 16.05M | 16.05M |
| Cost of revenue | 13.84M | 15.06M | 2.29M | 5.39M | 5.39M |
| Total other income expense net | -16.70M | 0.03M | -0.45M | -1.58M | -1.58M |
| Discontinued operations | - | - | - | 11.84M | 11.84M |
| Net income from continuing ops | -18.72M | -135.47M | -9.12M | -13.08M | -16.85M |
| Net income applicable to common shares | - | - | - | -1.36M | -16.85M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 189.63M | 214.95M | 142.02M | 50.68M | 50.68M |
| Intangible assets | 0.06M | 7.88M | - | - | - |
| Other current assets | 187.89M | 6.81M | 56.65M | 0.89M | 0.89M |
| Total liab | 8.71M | 15.80M | 3.59M | 38.39M | 38.39M |
| Total stockholder equity | 180.93M | 199.12M | 138.37M | 12.28M | 12.28M |
| Other current liab | 3.83M | 3.52M | 1.10M | 38.39M | 38.39M |
| Common stock | 0.26M | 0.17M | 0.04M | 0.01M | 0.01M |
| Capital stock | 0.26M | 0.17M | 0.04M | 0.01M | 0.01M |
| Retained earnings | -217.58M | -198.90M | -63.93M | -53.11M | -53.11M |
| Good will | 0.00M | 10.83M | - | - | - |
| Other assets | - | - | -0.40M | - | - |
| Cash | 0.17M | 176.23M | 85.17M | 21.93M | 21.93M |
| Total current liabilities | 8.71M | 13.81M | 3.59M | 38.39M | 38.39M |
| Current deferred revenue | 4.41M | 10.22M | 0.42M | 0.19M | - |
| Net debt | 0.21M | -176.15M | -85.17M | -21.93M | -21.93M |
| Short term debt | 0.37M | 0.04M | 2.00M | - | - |
| Short long term debt | 0.35M | - | - | - | - |
| Short long term debt total | 0.38M | 0.08M | 2.00M | - | - |
| Other stockholder equity | 401.54M | 401.63M | 206.34M | 67.03M | 67.03M |
| Property plant equipment | - | - | - | - | 0.06M |
| Total current assets | 189.55M | 196.12M | 142.02M | 50.62M | 50.62M |
| Net tangible assets | - | - | - | 8.73M | 12.28M |
| Net receivables | 1.28M | 12.90M | 56.25M | 20.02M | 20.02M |
| Inventory | 0.20M | 0.19M | 0.19M | 7.80M | 7.80M |
| Accounts payable | - | - | -2.00M | - | - |
| Accumulated other comprehensive income | -3.28M | -3.77M | -4.09M | -1.65M | -1.65M |
| Non currrent assets other | - | - | -141.62M | -0.27M | - |
| Non current assets total | 0.09M | 18.83M | 0.40M | 0.06M | 0.06M |
| Capital lease obligations | 0.03M | 0.08M | - | - | - |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Investments | - | -105.91M | -54.72M | 18.47M | -19.96M |
| Change to liabilities | - | - | - | 0.71M | -0.10M |
| Total cashflows from investing activities | -163.46M | -105.91M | -54.72M | 18.47M | -19.96M |
| Net borrowings | 0.35M | 0.00M | -7.69M | -27.51M | 24.76M |
| Total cash from financing activities | 0.35M | 195.88M | 131.65M | 34.78M | 34.78M |
| Change to operating activities | - | - | - | 0.10M | 5.51M |
| Net income | -18.72M | -135.47M | -9.12M | -16.85M | -16.85M |
| Change in cash | -176.06M | 90.03M | 77.01M | 6.80M | 6.80M |
| Begin period cash flow | 176.23M | 86.20M | 9.19M | 15.13M | 15.13M |
| End period cash flow | 0.17M | 176.23M | 86.20M | 21.93M | 21.93M |
| Total cash from operating activities | -12.79M | 1.18M | 1.35M | -8.63M | -8.63M |
| Issuance of capital stock | 0.00M | 195.88M | 139.34M | 0.00M | 10.02M |
| Depreciation | 2.37M | 2.15M | 0.00M | 0.02M | 0.02M |
| Other cashflows from investing activities | -163.46M | -12.01M | -54.72M | - | - |
| Change to inventory | 0.00M | 0.00M | 1.50M | -7.80M | -7.80M |
| Change to account receivables | -0.44M | -0.86M | 0.33M | 0.01M | 0.01M |
| Sale purchase of stock | - | - | - | - | 0.00M |
| Other cashflows from financing activities | - | - | 131.65M | 34.76M | 34.76M |
| Change to netincome | - | - | - | -0.72M | 10.77M |
| Capital expenditures | 175.67M | 0.15M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -11.35M | 3.02M | 2.06M | -2.56M | -2.56M |
| Stock based compensation | - | - | 0.00M | 0.39M | 0.39M |
| Other non cash items | 16.89M | 162.28M | 8.41M | 10.38M | 10.38M |
| Free cash flow | -188.46M | 1.02M | 1.35M | -8.63M | -8.63M |
Sector: Healthcare Industry: Medical Distribution
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHG Akso Health Group ADR |
0.10 8.12% |
1.35 | - | - | 47.07 | 3.60 | 47.09 | -0.39 |
| MCK McKesson Corporation |
-2.80 0.26% |
1079.79 | 24.45 | 20.41 | 0.26 | 5.04 | 0.27 | 15.03 |
| COR Cencora Inc. |
- -% |
349.88 | 24.22 | 16.39 | 0.19 | 20.41 | 0.21 | 13.72 |
| CAH Cardinal Health Inc |
0.66 0.24% |
277.45 | 29.48 | 17.92 | 0.20 | 16.07 | 0.22 | 15.67 |
| HSIC Henry Schein Inc |
- -% |
88.42 | 25.89 | 15.08 | 0.72 | 3.14 | 1.00 | 13.43 |
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
| Name | Title | Year Born |
|---|---|---|
| Ms. Yilin Wang | CEO & Chairwomen of the Board | NA |
| Ms. Rui Zhang | Chief Financial Officer | 1983 |
| Ms. Daisy Wang | Investor Relation Contact | NA |
| Ms. Ma Xiaoqin | Corp. Sec. | NA |
| Ms. Yilin Wang | CEO & Chairwoman of the Board | 1987 |
| Ms. Rui Zhang | Chief Financial Officer | 1984 |
| Ms. Ma Xiaoqin | Corporate Secretary | NA |
| Mr. Zhongliang Xie | Chief Financial Officer | 1971 |
| Mr. Zhongliang Xie | Chief Financial Officer | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.